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LIN28-mediated processing of the microRNA
(miRNA) let-7 has emerged as a multilevel program
that controls self-renewal in embryonic stem cells.
LIN28A is believed to act primarily in the cytoplasm
together with TUT4/7 to prevent final maturation of
let-7 by Dicer, whereas LIN28B has been suggested
to preferentially act on nuclear processing of let-7.
Here, we find that SET7/9monomethylation in a puta-
tive nucleolar localization region of LIN28A increases
its nuclear retention and protein stability. In the
nucleoli of human embryonic stem cells, methylated
LIN28A sequesters pri-let-7 and blocks its process-
ing independently of TUT4/7. The nuclear form of
LIN28A regulates transcriptional changes in MYC-
pathway targets, thereby maintaining stemness
programs and inhibiting expression of early line-
age-specific markers. These findings provide insight
into the molecular mechanism underlying the post-
translational methylation of nuclear LIN28A and its
ability to modulate pluripotency by repressing let-7
miRNA expression in human embryonic stem cells.
INTRODUCTION
LIN28 was originally identified as a regulator of developmental
timing in the nematode C. elegans (Ambros and Horvitz, 1984),
and its expression is tightly regulated during animal development
(Moss and Tang, 2003). Consistent with its role in development,
LIN28A is highly expressed in embryonic stem cells (ESCs) and is
one of four factors that convert human fibroblasts into induced
pluripotent stem cell (Yu et al., 2007b). Subsequent studies
have revealed that LIN28A and its paralog LIN28B are also
broadly involved in control of growth and metabolism, germ
cell development, and cancer (Viswanathan et al., 2009; West
et al., 2009; Zhu et al., 2011). Functionally, LIN28 proteins affectCellmRNA translation (Polesskaya et al., 2007) and specifically
repress the processing of let-7 miRNAs into mature forms that
mediate ESC differentiation, thereby modulating self-renewal
and pluripotency (Heo et al., 2008; Newman et al., 2008; Rybak
et al., 2008; Viswanathan et al., 2008). The primary transcript of
let-7 (pri-let-7) miRNAs are easily detectable in pluripotent
ESCs, whereas mature let-7 miRNAs are undetectable but
undergo posttranscriptional induction during differentiation
(Heo et al., 2008; Viswanathan et al., 2008), concomitant with
suppression of self-renewal pathways (Melton et al., 2010; Yu
et al., 2007a).
In the nucleus, LIN28A/B associate with the pri-let-7 to block
its Drosha-mediated processing to precursor let-7 (pre-let-7)
(Newman et al., 2008; Viswanathan et al., 2008). Regulation of
let-7 biogenesis involves direct interaction of LIN28A with the
terminal loop region of let-7; this requires both the cold shock
domain and a cluster of two CCHC-type zinc finger domains of
LIN28A (Nam et al., 2011; Piskounova et al., 2008). In the cyto-
plasm, the LIN28A protein directly interacts with pre-let-7 and
recruits the terminal uridylyltransferase TUT4/7 (Zcchc11/6)
to induce oligouridylation of pre-let-7, which subsequently
becomes targeted for degradation by the exoribonuclease
DIS3L2. This mechanism effectively blocks pre-let-7 processing
by Dicer and facilitates its rapid decay (Chang et al., 2013; Hagan
et al., 2009; Heo et al., 2009). In contrast, when LIN28A is absent
in somatic cells, TUT2/4/7 monouridylate pre-let-7 s, which en-
ables Dicer processing and maturation of let-7 (Heo et al., 2012).
LIN28A/B proteins are differentially localized in cells in a
variety of species, ranging from nematodes to mammals, with
LIN28A being predominantly found in the cytoplasm with some
distribution to the nucleus (Balzer and Moss, 2007; Chen and
Carmichael, 2009; Heo et al., 2008; Piskounova et al., 2011).
LIN28B is tagged by both a nuclear localization signal and a
nucleolar localization signal (NoLS) and is abundant in the nucle-
olus (Piskounova et al., 2011). Consistently, LIN28B is believed
to sequester pri-let-7 and block its processing by primarily acting
in the nucleus. However, LIN28A/B are not coexpressed in
mammalian cells with ubiquitous TUT4 expression, suggesting
that LIN28A and LIN28B in the cytoplasm both use TUT4/7-
dependent mechanisms for let-7 degradation (Heo et al., 2012;Stem Cell 15, 735–749, December 4, 2014 ª2014 Elsevier Inc. 735
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Figure 1. LIN28A Is Associated with and Methylated by SET7/9 in Cultured Cells and In Vitro
(A and B) Immunoprecipitation of endogenous LIN28A with SET7/9 from H9 cells was performed.
(C) Alignment of the consensus amino acid residues adjacent to lysines targeted for methylation by SET7/9. In each case, the target lysine is underlined and
bolded, and the asterisk indicates the consensus SET7/9 recognition sequence, K/R-S/T-K.
(D) Detection of monomethylated LIN28A from whole-cell extracts of 293T cells overexpressing FLAG-LIN28A wild-type or the FLAG-LIN28A-K135R mutant.
Samples were immunoblotted using the antibodies indicated on the right. b-Actin was used as a loading control.
(E) In vitro pull-down assays were carried out using GST-SET7/9 and 6xHIS-LIN28A or -K135R of full-length proteins.
(F) In vitro methyltransferase assay. Bacterially expressed recombinant full-length SET7/9 was incubated as indicated with full-length LIN28A or rC/H (positive
control) plus [3H] SAM. Autoradiography (top) and Ponceau S staining (bottom) were used to examine methylation and protein levels, respectively.
(legend continued on next page)
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decrease let-7 biogenesis via distinct mechanisms (Piskounova
et al., 2011). Although many studies have examined the mecha-
nism through which LIN28A regulates the let-7 miRNA in the
cytoplasmic compartment, our understanding of how LIN28A
functions in the nucleus is more limited. Notably, LIN28A is
tagged by a region that is highly homologous with the NoLS of
LIN28B.
Core pluripotency factors (e.g., OCT4, SOX2, NANOG, and/or
LIN28A) tightly modulate the states of ESCs transcriptionally
and/or posttranslationally (Boyer et al., 2005; Heo et al., 2008;
Melton et al., 2010; Viswanathan et al., 2008). Although it is
well known that the expression of these factors is coordinately
modulated at the transcription level (Boyer et al., 2005), little is
known about how posttranslational modifications (PTMs; e.g.,
methylation, acetylation, phosphorylation, and ubiquitylation)
may affect the subcellular localization, stability, protein-protein
interactions, and/or functions of these factors. Recently, epige-
netic modifiers have been shown to induce PTM of some
pluripotency factors, thereby regulating their functions and
contributing to pluripotency and self-renewal (Evans et al.,
2007; Fang et al., 2014; Moretto-Zita et al., 2010; Wang et al.,
2014; Wei et al., 2007). Whether PTMs of LIN28 proteins can
affect function in human ESCs (hESCs) remains unknown.
SET7/9 (SETD7) was originally identified as a protein methyl-
transferase that catalyzes monomethylation of histone 3
(Nishioka et al., 2002; Strahl and Allis, 2000; Tao et al., 2011).
However, it was later found to also regulate the activities of
nonhistone proteins, such as p53 (Chuikov et al., 2004), TAF10
(Kouskouti et al., 2004), DNMT1 (Este`ve et al., 2009), ERa (Sub-
ramanian et al., 2008), and E2F1 (Kontaki and Talianidis, 2010).
Consensus target residue analysis identified a structurally
conserved consensus recognition sequence in its substrates
(K/R-S/T-K, with K being the target lysine residue) (Couture
et al., 2006), and the authors proposed other putative target sub-
strates among the nonhistone protein pool in mammalian cells.
Recently, SOX2 was identified as a SET7/9 substrate in mouse
ESCs, targeting methylated SOX2 for degradation (Fang et al.,
2014), but little is known about its function in hESCs. Similar to
the high expression of LIN28A in skeletal muscle (Polesskaya
et al., 2007), the expression of SET7/9 is gradually increased dur-
ing skeletal muscle (Tao et al., 2011) as well as embryoid body
differentiation (Fang et al., 2014).
Here, we have examined the methylation of pluripotency fac-
tors and found that SET7/9 specifically monomethylates
LIN28A at lysine 135, which is in a region that is homologous
with the NoLS of LIN28B. Our results further suggest that
SET7/9-mediated methylation of LIN28A increases LIN28A pro-
tein stability and localization to the nucleus. Furthermore, we find
that LIN28A methylation stimulates multimerization of LIN28A
with let-7 miRNA. In hESCs, the methylated LIN28A inhibits pro-
cessing of the let-7 miRNA by sequestering its transcripts to the
nucleoli in a TUTase-independent manner, thereby regulating
pluripotency and differentiation.(G and H) In vitro methyltransferase assays were carried out with 6xHIS-LIN28A
rC/H used as a positive control (G) and with 11 full-length 6xHIS-LIN28A mutants
K150R, and K153R substitutions, as described above. A nonspecific band is ind
See also Figures S1 and S2.
CellRESULTS
LIN28A Is Monomethylated at K135 by the SET7/9
Lysine Methyltransferase in hESCs
Preliminary in vitro methylation analysis using SET7/9 and
the recombinant pluripotency factors showed that the SET7/9
protein was capable of methylating LIN28A (Figure S1A
available online). Consistent with a recent report (Fang et al.,
2014), SOX2 was also methylated by SET7/9, while OCT4
and NANOG were not methylated under the same conditions.
To investigate whether LIN28A is potentially regulated by
lysine methylation, we tested in vitro methylation analysis
using a variety of histone methyltransferases (HMTases).
SET7/9 specifically methylated LIN28A (Figure S1B). To verify
this finding, LIN28A was used to perform in vitro pull-down
assays with HMTases (Figures S1C–S1E). Although several of
the tested HMTases bound to the LIN28A protein, SET7/9
clearly showed the strongest enzymatic activity. Thus, we
speculated that LIN28A may be functionally modified by lysine
methylation.
To confirm the binding between LIN28A and SET7/9, we esti-
mated their physical interaction using an immunoprecipitation
assay in cultured cells. Endogenous or overexpressed LIN28A
was immunoprecipitated from H9, NCCIT, and 293T cells, and
subsequent immunoblotting with the relevant antibodies re-
vealed that SET7/9 was immunoprecipitated with LIN28A in all
three cell lines (Figures 1A, S1F, and S1G). LIN28A did not immu-
noprecipitate with the negative control immunoglobulin G (IgG).
Reverse immunoprecipitation of SET7/9 confirmed the identified
interaction with LIN28A (Figure 1B).
We next sought to identify the SET7/9-methylated residue(s) in
LIN28A. We compared the amino acid sequence of LIN28A with
the sequences surrounding the SET7/9 methylation sites of
target substrates (Figure 1C). We found that the conserved lysine
residue at position 135 and its neighboring residues of LIN28A
showed strong similarities to the consensus SET7/9 recognition
sequence (Couture et al., 2006). Interestingly, LIN28B does not
contain the SET7/9 recognition sequence. When we aligned
the full amino acid sequences of LIN28 proteins of various spe-
cies, we found that the identified SET7/9 recognition sequence
was evolutionarily conserved among the higher eukaryotes
(Figure S2A).
To facilitate studies on the SET7/9-mediated monomethyla-
tion of LIN28A at lysine 135 in cells, we generated polyclonal
antibodies that specifically recognized unmethylated LIN28A-
K135 or monomethylated LIN28A-K135. Next, we transfected
293T cells with a construct encoding FLAG-tagged LIN28A
wild-type or FLAG-LIN28A-K135R mutant (K135R; in which
lysine 135 was replaced with arginine). Immunoblot analysis
using the anti-LIN28A-K135-me1 (methylated) antibody re-
vealed the presence of methylated LIN28A in extracts prepared
from cells overexpressing LIN28A but not K135R (Figure 1D).
We therefore conclude that LIN28A is methylated at lysine
135 in cells.fragments, LIN28A (1–124), (125–209), (125–156), (157–209), and SET7/9 with
bearing the K78R, K88R, K98R, K99R, K102R, K125R, K127R, K131R, K135R,
icated by an asterisk (H).
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Figure 2. SET7/9 Increases the Stability of LIN28A through Lysine Methylation
(A) 293T cells were transfected with plasmids encoding FLAG-LIN28A or FLAG-LIN28A-K135R alone or together with HA-SET7/9, as indicated. Forty-eight hours
after transfection, whole-cell extracts were immunoblotted using the antibodies indicated on the right. b-Actin was used as a loading control. A representative
(legend continued on next page)
Cell Stem Cell
The Nuclear Form of LIN28A Is Methylated by SET7/9
738 Cell Stem Cell 15, 735–749, December 4, 2014 ª2014 Elsevier Inc.
Cell Stem Cell
The Nuclear Form of LIN28A Is Methylated by SET7/9SET7/9 Associates with and Methylates LIN28A In Vitro
To determine whether the interaction between LIN28A and
SET7/9 in cells is direct, we generated a series of MAL, 6xHIS,
and GST fusion proteins containing various truncated versions
of LIN28A and SET7/9 (Figures S1D and S1E), and used them
to perform pull-down assays. Our results revealed that the
carboxyl terminus (amino acids 125–209) of LIN28A interacted
with SET7/9 (Figures S1H and S2C). Both LIN28A and the
K135R bound to SET7/9 in this assay (Figure 1E). These results
suggest that the LIN28A and SET7/9 proteins interact directly.
We next examined whether SET7/9 could methylate LIN28A
in vitro. When recombinant full-length LIN28A was incubated
with recombinant SET7/9 in the presence of 3H-S-adenosine-
methionine ([3H]SAM),we found thatLIN28Awasmethylated (Fig-
ure 1F, lane 2). LIN28A was not methylated in the absence of the
SET7/9protein (Figure1F, lane 3), indicating that LIN28A is indeed
methylated by SET7/9 in vitro. As a positive control, recombinant
human core histone (rC/H) was also shown to be methylated by
SET7/9 under the same conditions, validating our in vitro methyl-
transferase assay (Figure 1F, lanes 4 and 5, and Figure S2F).
Given that full-length LIN28A is methylated in cultured cells
and in vitro by SET7/9, we next sought to confirm that K135 of
LIN28A is a bona fide SET7/9 target. We purified 6xHIS-tagged
proteins containing four different fragments of LIN28A and
used them as substrates for an in vitro methyltransferase assay.
Of the four tested fragments, LIN28A (125–209) and (125–156),
which included K135, were methylated by SET7/9 (Figure 1G,
lanes 4 and 6). In contrast, LIN28A (1–124) and (157–209), which
did not include K135, showed no evidence of methylation (Fig-
ure 1G, lanes 2 and 8). Because there are numerous lysine
residues surrounding K135, we confirmed this result by running
parallel experiments in which we substituted eleven lysines with
nonmethylatable arginines. A single-point mutation at K135R,
but not the other tested lysines, completely eliminated SET7/9-
mediated methylation (Figure 1H, lane 19), providing additional
evidence that SET7/9 methylates LIN28A at K135.
Because LIN28Bdoes not have the SET7/9 target residue (Fig-
ure 1C), we performed in vitro methyltransferase assays using
LIN28B to investigate the specificity of the SET7/9-induced
methylation of LIN28A at K135. As expected, LIN28B was not
methylated by SET7/9 (Figure S2D). In the context of a negative
control, DOT1L (a H3K79 methyltransferase) was purified from a
baculovirus expression system (Kim et al., 2012) and used in our
methyltransferase assay. It failed to methylate LIN28A (Fig-
ure S2E). Collectively, these results indicate that the SET7/9-
mediated methylation of LIN28A at K135 is specific.
SET7/9 Stabilizes LIN28A via Lysine Methylation
SET7/9-mediated lysine methylation is known to regulate the
stability of various K/R-S/T-K-containing targets. Therefore, we
examined whether methylation by SET7/9 affects the stability ofresult from three independent biological replicates is shown (left). The LIN28A s
compared with b-actin. Error bars denote SDs obtained from three independent
(B) Real-time quantitative RT-PCR (RT-qPCR) was used to measure the mRNA lev
expression of GAPDH. Error bars denote SDs obtained from three independent
(C) 293T cells were transfected as indicated, and cells were treated with 60 mg/m
right. Quantification of the results (right) was obtained as described as in (A).
(D and E) Immunoblotting was performed as described above, using whole-cell
CellLIN28A in cells. Coexpression of SET7/9 in 293T cells upregu-
lated the expression of LIN28A but not K135R (Figure 2A),
suggesting that the SET7/9-mediated methylation of LIN28A
may increase its stability. Further supporting this notion, the co-
expression of SET7/9 did not alter the mRNA levels of LIN28A
(Figure 2B). To assess whether this apparent stabilization was
associated with the methylation of LIN28A at K135, we investi-
gated the effect of SET7/9 on the half-life of LIN28A and K135R
using cycloheximide (CHX), a protein synthesis inhibitor. We
found that theSET7/9-mediatedmethylationof LIN28Apromoted
its stabilization and increased its half-life, whereas the half-life
of K135R was reduced (Figure 2C). Furthermore, depletion of
SET7/9 in H9 and NCCIT cells by transfection of small interfering
RNA (siRNA) also affected stabilization of LIN28A (Figures 2D
and 2E). Together, these data show that the SET7/9-mediated
methylation of LIN28A at K135 increases the stability of LIN28A.
Monomethylated LIN28A Is Specifically Localized in the
Nucleoli
Notably, K135 and its neighboring sequences in LIN28A are
homologous with the NoLS of LIN28B (Figures S1H and S3A)
(Piskounova et al., 2011). In order to determine whether methyl-
ated LIN28A preferentially localizes to either cellular compart-
ment, we prepared nuclear and cytoplasmic fractions from either
293T cells (which do not endogenously express LIN28A), by
exogenously expressing LIN28A or LIN28A-K135R or from H9
or NCCIT cells (which endogenously express LIN28A). These
fractions were immunoblotted with the indicated antibodies (Fig-
ures 3A and 3B; Figure S3B). Consistent with the published data,
we found that LIN28A (the cytoplasmic form) was abundant in
the cytoplasm of all tested cells. A smaller portion localized to
the nucleus, largely the methylated form (the nuclear form) (Fig-
ure 3A, lane 5, and Figure 3B, lanes 1 and 2). Intriguingly, the
methylated form of LIN28A specifically localized to both the
nucleoli and the nucleoplasm of H9 cells (Figure 3C). These
data were further confirmed by immunofluorescence assays in
H9, NCCIT, and 293T cells, wherein abundant monomethylated
LIN28A was detected along with SET7/9 in the nucleus; this was
especially evident in the nucleoli (Figures 3D, S3C, and S3D).
To further support our proposal that the nuclear localization of
monomethylated LIN28A is due to SET7/9-mediated methyl-
ation, we subjected SET7/9 to siRNA-mediated knockdown
and used immunoblotting and immunofluorescence assays to
show that the specific nuclear localization pattern of the nuclear
form of LIN28A was diminished in these cells (Figure 3E). The
signal intensity levels of LIN28A and SET7/9 were also quantified
in control and SET7/9-siRNA-treated H9 cells (Figure 3F). Taken
together, these data suggest that K135-monomethylated
LIN28A may function in a manner similar to the NoLS of
LIN28B. Sequence alignment of the LIN28 homologs further sup-
ported this idea (Figure S3A).ignals were quantified and are given in arbitrary units of band intensity (right)
biological replicates.
els of LIN28A and SET7/9, and the results were normalized with respect to the
biological replicates.
l of CHX. Samples were immunoblotted using the antibodies indicated on the
extracts from single H9 and NCCIT cells.
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Figure 3. Methylated LIN28A Is Located Mainly in the Nucleus
(A) 293T cells were transfected with control vectors or vectors encoding FLAG-LIN28A or FLAG-LIN28A-K135R. Nuclear and cytoplasmic fractions were
immunoblotted using the antibodies indicated on the right. H3 was used as a nuclear marker, while a-tubulin was used as a cytoplasmic marker. The
LIN28A signals were quantified and are given in arbitrary units of band intensity (right). Error bars denote SDs obtained from three independent biological
replicates.
(B) Nuclear or cytoplasmic fractions from H9 cells were immunoblotted for endogenous LIN28A using the antibodies indicated on the right. H3 was used as a
nuclear marker, and a-tubulin was used as a cytoplasmic marker.
(C) Nuclear fractions from H9 cells were further fractionated to nucleolar or nucleoplasmic subfractions, and immunoblotting was performed using the antibodies
indicated on the right. Fibrillarin was used as a nucleolar marker.
(D) Immunofluorescent detection of endogenous LIN28A, LIN28A-me1, fibrillarin, and SET7/9 in H9 cells. Scale bars represent 400 and 50 mm (for colony
formation).
(legend continued on next page)
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Figure 4. Methylated LIN28A Is a Truly
Active Form that Blocks the Processing of
pri-let-7 miRNAs
(A) 293T cells were cotransfected with human pri-
let-7a-1, and the protein expression vectors,
FLAG-LIN28A, FLAG-LIN28A-K135R, or FLAG-
AGO2 along with the renilla (pRL-CMV) and firefly
(let-7aBS-Luc, a luciferase construct containing
three binding sites of let-7a-1 in its 30UTR that can
be targeted by mature let-7a-1) luciferase genes,
as indicated. RT-qPCR was used to measure the
relative expression levels of let-7aBS-Luc, pri-let-
7a-1, and mature let-7a-1. The firefly luciferase
signal was normalized with respect to that from
renilla, and each value was normalized with
respect to that of GAPDH. The U6 small nuclear
RNA (snRNA) was used as a reference for
the mature let-7a-1 levels. Error bars denote
SDs obtained from three independent biological
replicates.
(B) Vectors were cotransfected as indicated into
293T cells, and RT-qPCR was used to evaluate
the relative expression levels of miR-16BS-Luc
(containing one binding site for miR-16), pri-miR-
16-1, and mature miR-16-1. The values were
normalized as described in (A). Error bars denote
SDs obtained from three independent biological
replicates.
(C) RT-qPCR showing changes in the levels of
endogenous primary (top) or mature (bottom) let-
7a miRNAs and control miRNA upon knockdown
of the LIN28A,SET7/9, or TUT4 in H9 cells.GAPDH
and the U6 snRNA were used as references for the
primary and mature miRNAs, respectively.
See also Figure S4 and Table S1.
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Processing in the Nucleus
Compared with the localization of LIN28B (Piskounova et al.,
2011), methylation of LIN28A appears to be an exclusive signal
that simultaneously increases LIN28A protein stability and di-
rects subcellular localization (Figures 2, 3, and S3). On the basis(E) Immunoblotting was performed as described above, using nuclear and cytoplasmic fractions fromH9 cells
control or SET7/9 (left). Immunofluorescent analysis of H9 cells subjected to siRNA-mediated knockdown a
(F) The signal intensities of LIN28A and SET7/9 shown in (E) were quantified and are given in arbitrary units (n =
(as determined with DAPI staining) were used for measurements. The nucleus (Nuc) and cytoplasm (Cyt) ar
See also Figure S3.
Cell Stem Cell 15, 735–749,of these results, we hypothesized that
monomethylated LIN28A may function
within the nucleus to regulate the pro-
cessing of pri-let-7-1 miRNA in a
TUTase-independent manner (similar to
the parallel function of LIN28B) and
explored whether nuclear LIN28A can
inhibit miRNA processing. Cotransfection
of human pri-let-7a-1 and let-7aBS-Luc
with either FLAG-LIN28A or FLAG-
K135R led to accumulation of pri-let-
7a-1 RNAs and luciferase mRNAs, which
was accompanied by a corresponding
accumulation in the levels of mature let-7a-1 RNAs (Figure 4A). Notably, substantially more pri-let-7a-1
RNAs were accumulated by the nuclear form compared with
the cytoplasmic form of LIN28A (Figure 4A, lanes 4 and 5), which
is consistent with the differences in their nuclear levels (Fig-
ure 3A). The levels of mature let-7miRNAs, however, were some-
what decreased also by cytoplasmic form of LIN28A (Figure 4A,subjected to siRNA-mediated knockdown of EGFP
s indicated (right). Scale bar represents 400 mm.
8). Pairs of cells with nuclei of the same scan width
e indicated.
December 4, 2014 ª2014 Elsevier Inc. 741
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cytoplasm to block the processing of let-7. As a control,
the expression of AGO2, which is a catalytic component of the
RNA-induced silencing complex known to repressmiRNA-medi-
ated translation (Heo et al., 2008), triggered an2-fold decrease
of luciferasemRNA levels (Figure 4A, lane 6). Similar results were
obtained with another let-7 family member, pri-let-7g (Figures
S4C and S4D), but not with the negative control, miR-16-1 (Fig-
ure 4B), indicating that the nuclear LIN28A specifically targets
let-7 family members.
To explore whether the nuclear LIN28A is capable of inhibiting
the processing of endogenous let-7 miRNAs, we measured the
levels of all mature let-7 miRNAs in 293T cells expressing
FLAG-LIN28A or FLAG-K135R (Figure S4E). All of the tested
endogenous pri-let-7 miRNAs showed considerably more upre-
gulation in cells overexpressing LIN28A versus K135R mutant,
whereas the levels of endogenous mature miR-16 and miR-21
were unaffected (Figure S4F, top). The nuclear LIN28A-induced
decreases in the levels of mature let-7 miRNAs were accompa-
nied by corresponding accumulations of pri-let-7 (Figure S4F,
bottom). Next, we examined whether the nuclear LIN28A is an
endogenous inhibitor of miRNA biogenesis in hESCs. We used
siRNAs targeting LIN28A or SET7/9 to knock down the expres-
sion of endogenous LIN28A or SET7/9 in H9 hESCs (Figures
4C and S4G). Knockdown of LIN28A led to a remarkable in-
crease of mature let-7 miRNAs in H9 cells, while levels of other
negative control miRNAs were unchanged (Figure 4C, bottom).
Mature let-7 miRNAs likely accumulated because of the long
half-lives of mature miRNAs (Kim, 2005). The accumulation of
mature let-7 miRNAs in LIN28A-knockdown cells was accompa-
nied by a corresponding decrease in pri-let-7 (Figure 4C, top).
Similar results were obtained in SET7/9-knockdown cells, in
which decreased LIN28Amethylation was associated with upre-
gulation of mature let-7 (Figures 4C and S4F, green). A smaller
increase in the most mature let-7 miRNAs was observed in
TUT4-depleted cells compared with LIN28A- or SET7/9-
depleted cells, while pri-let-7 miRNAs were unaffected (Fig-
ure 4C, purple) (Hagan et al., 2009; Heo et al., 2009). Together,
these results strongly suggest that the nuclear LIN28A (i.e., the
active form) blocks the processing of pri-let-7 in the nucleus.
Nuclear LIN28A Is Efficiently Multimerized on Primary
let-7 miRNA
To further investigate the mechanism through which nuclear
LIN28A blocks let-7 processing, we compared the relative bind-
ing abilities of the nuclear and cytoplasmic forms of LIN28A with
let-7 RNA (Figures 5A–5C). Previous reports suggest that multi-
ple molecules of LIN28A assemble on let-7 RNA to fulfill its
maximum inhibitory function on let-7 biogenesis (Desjardins
et al., 2014). We carried out electrophoretic mobility shift assay
(EMSA) with pri- or pre-let-7a-1. Surprisingly, we found
increased multimeric binding of the nuclear LIN28A on pri-let-
7a-1, especially as a trimer, compared to the cytoplasmic form
(Figure 5B). The faster formation of multimeric complexes by
the nuclear LIN28A was accompanied by a corresponding
decrease in monomer (Figure 5B, 60 and 80 nM). The average
ratio of the trimer band of the nuclear LIN28A over that of the
dimer (2.49-fold) was much higher than that of cytoplasmic
form (0.61-fold) (Figures 5B, S5A, and S5B), suggesting much742 Cell Stem Cell 15, 735–749, December 4, 2014 ª2014 Elsevier Infaster binding of the nuclear LIN28A to pri-let-7. We also verified
that both nuclear and cytoplasmic forms of LIN28A bind to pre-
let-7a-1 with similar affinities (Figures 5C, S5C, and S5D).
Together with the above-described data (Figures 2, 3, and 4),
these assays strongly indicate that multiple assembly of the
nuclear LIN28A on pri-let-7 miRNA may efficiently isolate and
stabilize LIN28A-RNA complexes, thereby more efficiently inhib-
iting its biogenesis in the nucleoli.
To gain further insight into our evolving model, in which the
nuclear LIN28A multimerizes to and blocks the processing of
pri-let-7, we next investigated the association of RNAs with the
nuclear LIN28A in cells. Endogenous or overexpressed LIN28A
was targeted for RNA immunoprecipitation (RIP) analyses
using antibodies against control IgG, LIN28A (detecting both
methylated and unmethylated LIN28A), LIN28A-K135-me1, or
LIN28A-K135-me0, and the relative levels of pri-let-7a-1 copuri-
fied with LIN28A were quantified. Our data revealed that the nu-
clear LIN28A binds to pri-let-7a-1 RNA in the nucleus, whereas
the cytoplasmic LIN28A does not (Figures 5D and 5E). Substan-
tially more pri-let-7a-1 associated with the nuclear LIN28A using
whole-cell extracts (Figure S5E). The anti-LIN28A and anti-
LIN28A-K135-mel antibodies detected 2.8- and 5.6-fold enrich-
ments, respectively, of pri-let-7a-1 associated with the nuclear
LIN28A in the nucleus (Figure 5D) and 20.0- and 20.8-fold enrich-
ments, respectively, of pri-let-7a-1 in the nucleus and cytoplasm
(Figure 5E). The degree of enrichment between LIN28A-me0 and
LIN28A-K135-me0 signals did not significantly differ between
the two proteins, suggesting that most of the methylated
LIN28A was bound to pri-let-7a-1 in the nucleus. On the basis
of these findings, together with the above data (Figures 2, 3,
and 4), we strongly suggest that nuclear form of LIN28A directly
targets pri-let-7 miRNA to modulate its processing.
Nuclear LIN28A and SET7/9 Modulate Stem Cell
Pluripotency and Differentiation by Regulating let-7
Maturation
Consistent with the previous report (Viswanathan et al., 2008),
we found that increased levels of mature let-7 miRNA in ESCs
were accompanied by decreased pri-let-7 (Figure 4C). We next
evaluated the importance of LIN28A and SET7/9 in let-7-medi-
ated regulation of pluripotency in H9 cells. Transfection with
LIN28A- or SET7/9-siRNA reduced protein levels of LIN28A or
SET7/9 respectively (Figures S6A and S6B). Interestingly,
LIN28A knockdown did not affect expression of representative
pluripotency genes, NANOG and SOX2, compared with cells
transfected with control EGFP-siRNA (Figure S6B).
Let-7 miRNA can participate in downregulation of two MYC
family members, MYC and MYCN, an activity that may reduce
cell ‘‘stemness’’ (Melton et al., 2010; Smith et al., 2010). MYC
and MYCN have shared functions in embryonic development
and cellular growth (Malynn et al., 2000), and have largely over-
lapping target genes (Chen et al., 2008). To assess whether the
SET7/9-mediated methylation of LIN28A affects stemness
through regulation of let-7, we performed genome-wide tran-
scriptional expression profiling and then analyzed the expression
of MYC-pathway targets (Ji et al., 2011) in LIN28A-, SET7/9-, or
TUT4-depleted H9 cells (Figure 6 and Tables S3, S4, and S5).
Genes activated by MYC pathway were significantly downregu-
lated upon LIN28A knockdown, whereas those repressed byc.
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Figure 5. Pri-let-7 May Have a Preference for the Nuclear Form of LIN28A
(A) Coomassie blue staining of purified FLAG-LIN28A and FLAG-LIN28A-K135R proteins (left). Purified FLAG-LIN28A and FLAG-LIN28A-K135R proteins were
immunoblotted using the indicated antibodies (right).
(B and C) EMSA of pri- (B) or pre-let-7a-1 miRNA (C) with purified FLAG-LIN28A or FLAG-LIN28A-K135R. Unbound, monomer, dimer, and trimer indicate the
multimeric binding of purified proteins to pri-let-7a-1 miRNA. Bottom: Schematic diagrams of EMSA with pri- (B) or pre-let-7a-1 (C) are shown. Unbound,
monomer, dimer, and trimer fractions are indicated by blue, red, green, and purple bars, respectively. Each fraction was quantitated from three independent
biological replicates.
(D and E) RIP assay. Nuclear and cytoplasmic fractions were prepared from 293T cells transfected with FLAG-LIN28A or FLAG-LIN28A-K135R (D) or H9 (E), and
RIP analyses were carried out with the indicated antibodies. All signals were normalized with respect to the input signal. Error bars denote SDs obtained from
three biological replicates, each consisting of three qPCRs.
See also Figure S5.
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The Nuclear Form of LIN28A Is Methylated by SET7/9MYC pathway were significantly upregulated upon LIN28A
knockdown (Figure 6A, left). Similar results were obtained in
SET7/9-knockdown cells in which LIN28A methylation was
associated with stemness through downregulation of mature
let-7 (Figure 6A, right). The moderate changes of MYC-pathway
targets between the expression changes were observed upon
TUT4 knockdown compared with LIN28A and SET7/9 knock-Celldown (Figure 6B), which is consistent with the differences in their
abilities to regulate mature let-7 levels (Figure 4C). Simulta-
neously, the expression changes of MYC pathway positive (red
dots) or negative (blue dots) targets induced by LIN28A and
SET7/9, by LIN28A and TUT4, and by SET7/9 and TUT4 showed
same patterns in which red or blue dots were down or up in both
conditions, and a positive correlation was observed betweenStem Cell 15, 735–749, December 4, 2014 ª2014 Elsevier Inc. 743
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Figure 6. Expression Profiles in LIN28A-, SET7/9-, and TUT4-Depleted hESCs
(A and B) Box plots showing the expression change (log2 ratio) of theMYC-pathway targets (Ji et al., 2011) in comparisonwith all genes in LIN28A-, SET7/9- (A), or
TUT4-depleted hESCs (B) (p = 0.0 and p = 0.0037, p = 0.0 and p = 0.0033, and p = 0.0 or p = 0.043 for the MYC pathway positive and negative genes in LIN28A-,
SET7/9-, or TUT4-depleted cells, respectively).
(C and D) Scatterplot comparing the expression change (log2 ratio) of the MYC-pathway targets (red and blue dots indicating the positive and negative genes,
respectively) induced by each experiment as described in (A and B).
(E) Box plots showing the expression change (log2 ratio) of theMYC-pathway targets in comparison with all genes in LIN28A-depleted hESCs with transfection of
LIN28A-siR or K135R-siR at the same time (p = 0.0 and p = 0.195, and p = 0.0 and p = 0.397 for the MYC pathway positive and negative genes LIN28A-siR or
K135R-siR, respectively). The increase of the MYC pathway positive genes is more distinct (p = 0.03) in LIN28A-siR than in K135R-siR (middle).
See also Figures S6 and S7 and Tables S3, S4, S5, S6, and S7.
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The Nuclear Form of LIN28A Is Methylated by SET7/9them (Figures 6C and 6D). Taken together, these proteins appear
to have shared functions in regulating the MYC pathway.
To further determine the specific contribution of LIN28A
methylation to transcriptional changes, we expressed nuclear
LIN28A-siR or cytoplasmic K135R-siR, resistant to LIN28A-
siRNA because of the silent mutations in target sequences (Fig-
ure S6D and S6E), in H9 cells, which were then subjected to
knockdown of endogenous LIN28A. The expression of the
nuclear or cytoplasmic LIN28A caused the activation of the
MYC pathway positive targets and the repression of the MYC744 Cell Stem Cell 15, 735–749, December 4, 2014 ª2014 Elsevier Inpathway negative targets (Figure 6E; Tables S6 and S7). How-
ever, theMYC pathway positive genes were activated to a higher
degree (p = 0.03) by the nuclear LIN28A than by the cytoplasmic
LIN28A (Figure 6E, middle), suggesting that the trimerization of
the nuclear LIN28A on pri-let-7 may facilitate transcriptional
changes through maximum inhibition of let-7 processing. The
repression of positive and activation of negative genes upon
K135R-siR expression was milder than expected, although the
contribution of LIN28A methylation in transcriptional changes
wasmore significant. This may be due to the additional inhibitoryc.
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The Nuclear Form of LIN28A Is Methylated by SET7/9effect of cytoplasmic LIN28A in TUTase-dependent let-7 pro-
cessing in overexpressed condition. Furthermore, the overall
level of H3K4 methylations and the occupancy of H3K4 mono-
methylation for the transcriptional regulation of MYC-pathway
targets were not severely affected upon SET7/9 knockdown
(Figure S7), and the SET7/9 knockdown closely mimics LIN28A
knockdown (Figures 4C, 6A, 7A, and 7C). Thus, we suggest
that SET7/9 seems to mostly induce the transcriptional changes
of MYC-pathway targets through LIN28A, although we cannot
rule out other functions of SET7/9 beyond the regulation of
LIN28A.
To further support this observation, we evaluated the ex-
pression levels of early lineage markers and observed that
knockdown of LIN28A or SET7/9 increased the expression of
representative early lineage markers, while TUT4 knockdown
moderately increased these markers (r = 0.40–0.95) (Figure 7A),
which is consistent with the above data (Figure 4C). The expres-
sion of nuclear LIN28A efficiently inhibited expression of early
lineage markers (r = 0.52) compared with the cytoplasmic form
(Figure 7B), suggesting that LIN28A methylation has a specific
function in pluripotency. A comparative analysis confirmed that
expression patterns observed in our microarray analyses were
reliable (Figure S6C). These data were further confirmed by
immunofluorescence assays in H9 cells, in which moderate but
consistent reductions in expression of ES-specific surface anti-
gens (TRA-1-60 and SSEA-4) and pluripotency marker ALP
were observed, while the control marker (SOX2) was unaffected
upon LIN28A and SET7/9 knockdown (Figure 7C). The observed
marginal reduction in OCT4 confirms previous reports suggest-
ing that OCT4 expression is posttranscriptionally decreased by
LIN28A depletion (Qiu et al., 2010). Those markers were not
significantly affected upon TUT4 knockdown (Figure 7C, bot-
tom). Notably, LIN28A-siR expression efficiently sustained the
pluripotency and suppressed differentiation of hESCs subjected
to LIN28A depletion compared with vector or K135R-siR expres-
sion (Figure 7D). Collectively, our findings suggest that LIN28A
and SET7/9 play key functions in regulating pluripotency in
hESCs via modulation of the let-7 miRNA.
DISCUSSION
In recent years, it has become clear that histones are not the sole
physiological substrates of the histone-modifying enzymes and
that PTMs, alone or together with other specific modifications
of nonhistone proteins, may play equally critical roles in diverse
intracellular pathways (Freiman and Tjian, 2003; Gu and Roeder,
1997; Turner, 2002). This was further supported by the ‘‘protein
code’’ hypothesis, which was based on the ‘‘histone code’’ hy-
pothesis (Jenuwein and Allis, 2001; Strahl and Allis, 2000).
Here, we reveal that LIN28A is specifically monomethylated at
K135 by SET7/9, an exclusive H3K4 monomethyltransferase.
This SET7/9-mediated methylation significantly contributes to
the protein stability, the multimeric binding to pri-let-7, and sub-
cellular localization of LIN28A to the nucleus. In pluripotent cells,
we suggest that the LIN28A methylation signal in the nucleus
might be a prerequisite for maximally inhibiting the processing
of let-7 miRNA, thereby modulating pluripotency and differentia-
tion. Together, these results provide amechanism throughwhich
methylation regulates the function of LIN28A in hESCs.CellThe K135 and its surrounding residues within LIN28A have
sequential homology to the NoLS of LIN28B (Figures 1, S1H,
and S3A) (Piskounova et al., 2011), suggesting that LIN28A/B
may share a specific role in the nucleoli (Figures 3 and 4). The
SET7/9-mediated methylation of LIN28A may allow this region
to function in a manner similar to the NoLS of LIN28B and to
act as a switch that causes nuclear retention of LIN28A, explain-
ing why a methylated LIN28A is found in the nucleoli of ESCs.
This LIN28A methylation signal in the nucleus stimulates the
faster formation ofmethylation-relatedmultimeric binding, which
may function as an active nuclear retention signal, especially in
the nucleoli, that may efficiently isolate and protect LIN28A/
let-7 from degradation, thereby stabilizing it. Notably, the micro-
processor components DGCR8 and Drosha are absent in
nucleoli (Piskounova et al., 2011), suggesting that sequestration
of pri-let-7 to this cellular compartment has evolved as a mech-
anism to withhold a pool of nuclear pri-let-7 from processing.
Interestingly, overexpressed FLAG-LIN28A was remarkably
methylated by endogenous SET7/9 in 293T cells (Figures 1D,
2A, S4A, and S4B). This finding led us to speculate that the pre-
viously reported ability of LIN28A to block pri-let-7 processing in
the nucleus of 293T cells (Heo et al., 2008; Viswanathan et al.,
2008) may reflect the function of methylated LIN28A. For the
sophisticated regulation of coding or noncoding RNA stability
and processing (Shyh-Chang and Daley, 2013), we suggest
that a limited quantity of LIN28A may be retained in the nucleus
via the methylation signal (Figures 3 and S3). If the quantitative
balance between LIN28A and its target RNAs is disrupted in
the nucleus, diverse cellular processes that may affect stemness
might be triggered, such as off-target effects through binding to
nonspecific RNAs, inappropriate RNA splicing and processing,
and miRNA-directed transcriptional gene silencing (Benhamed
et al., 2012; Shyh-Chang and Daley, 2013). Collectively, the
delicate methylation-mediated regulation of the quantity and
quality of LIN28A in the nucleus appears to be necessary to spe-
cifically control the stability and processing of RNAs, including
let-7 in ESCs.
The methyltransferase of LIN28A, SET7/9, is located in the nu-
cleus, and surprisingly the methylated nuclear LIN28A seems to
rapidly form the multimeric complex on pri-let-7 miRNA rather
than the unmethylated cytoplasmic LIN28A (Figures 3 and 5),
which may be transported to the nucleus though a methylation-
independent mechanism. Our group and others have found
that multimeric binding appears to be correlated with efficient
sequestration of pri-let-7 in nucleoli and maximum inhibition of
its processing (Figure 4) (Desjardins et al., 2014). Thus, we spec-
ulated about the presence of a binding partner (or complex) and
shuttle systemof the nuclear LIN28Abetween nucleoli and nucle-
oplasm, and the LIN28A-pri-let-7-multimeric complex may
rapidly enter the nucleoli through a shuttle system to significantly
inhibit the microprocessor-mediated cleavage of pri-let-7 (Des-
jardins et al., 2014; Viswanathan et al., 2008). Indeed, the multi-
meric assembly may indicate the presence of multiple binding
sites on the multimeric complex (Desjardins et al., 2014). A bind-
ing partner may specifically recognize that nuclear LIN28A be-
longs to themultimeric complex and rapidly take it to the nucleoli
faster than the LIN28A monomeric or dimeric complex. Further
studies are required to examine the potential mechanism(s)
responsible for the specific recognition of the nuclear LIN28AStem Cell 15, 735–749, December 4, 2014 ª2014 Elsevier Inc. 745
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The Nuclear Form of LIN28A Is Methylated by SET7/9by a binding partner (or together with its shuttle system) and the
fate aswell as the role of themultimeric complex in the nucleoli of
ESCs for the dynamic functional regulation of let-7 miRNAs to
understand the various regulatory pathways of pluripotency.
Induction of early lineage markers in LIN28A-knockdown cells
was milder than expected (Figure 7A). This may be due to the
modest changes in the levels of pluripotency factors (Figures
7B and S6B) and suggests that induction of lineage-specific
markers may be predominantly dependent on let-7-mediated
differentiation during this period. Therefore, induction of mature
let-7 appears to occur via direct action of nuclear LIN28A on pri-
let-7 biogenesis and cytoplasmic LIN28A on pre-let-7 miRNA
biogenesis, rather than indirect effects of differentiation medi-
ated by other factors. Indeed, several known target genes of
let-7 (e.g., RAS,MYCN, CDC25A, and CCND2) were moderately
but consistently affected during early stages of differentiation
(r = 0.98) (Figure S6F).
Our present work and other studies (Heo et al., 2008; Newman
et al., 2008; Rybak et al., 2008; Viswanathan et al., 2008) reveal
that LIN28A functions in both the nucleus and cytoplasm to block
let-7 processing. Although we show that the nuclear LIN28A and
LIN28B can bind to both pri- and pre-let-7 RNAs in Figures 5B
and 5C and other reports (Heo et al., 2008; Viswanathan et al.,
2008), and it remains formally possible that the nuclear
LIN28A/Bmay localize in the cytoplasm to efficiently use TUTase
in certain contexts or cell types (Guo et al., 2006; Heo et al.,
2008), the nuclear LIN28A/B mostly functions in the nucleus to
sequester and inhibit the processing of pri-let-7 miRNAs via a
TUTase-independent mechanism (Piskounova et al., 2011).
Indeed, pri-let-7 miRNAs seem to be a better binding substrate
of the nuclear LIN28A (Figures 5B–5E). Thus, the LIN28-medi-
ated regulation of pri-let-7 in the nucleus may be a critical block-
ading step in the let-7 miRNA-processing pathway. Intriguingly,
the expressions of LIN28A/B are mutually exclusive in diverse
cells (Piskounova et al., 2011), and compensatory redundancy
has been observed between them (Wilbert et al., 2012). Thus, it
appears likely that nuclear LIN28A may take over the function
of LIN28B in certain types of cells, such as embryonic cells,
certain differentiated cells, and the various cancer cells that
exhibit depletion of LIN28B.
EXPERIMENTAL PROCEDURES
Detailed procedures can be found in Supplemental Experimental Procedures.
In Vitro Methyltransferase Assays
In vitro methyltransferase assays were performed with recombinant proteins.
Protein preparation is described in Supplemental Experimental Procedures.
Cell Lines
H9 hESCs were cultured in ESC medium and grown on mouse embryonic
fibroblast treated with mitomycin C (Sigma-Aldrich). NCCIT and 293T cellsFigure 7. Nuclear LIN28A Is Critical for Regulating Stem Cell Maintena
(A and B) The expression levels of representative early lineage markers in LIN28
followed by transfection with control vector, LIN28A-siR, or K135R-siR (B), as det
profiles of the top-scoring genes are shown.
(C and D) Immunofluorescent detection of endogenous TRA-1-60, SSEA-4, OC
mediated knockdown of control, LIN28A or SET7/9 (C) and LIN28A-depletion wi
Scale bar represents 50 mm.
See also Figure S6.
Cellwere cultured in RPMI 1640 (GIBCO) and Dulbecco’s modified Eagle’s
medium (Hyclone). All cells were maintained at 37C, 5% CO2.
EMSA
EMSA was performed as described (Piskounova et al., 2008). Briefly, purified
nuclear FLAG-LIN28A or FLAG-LIN28A-K135R proteins were reacted with
1.3nM of 50-end 32P-labeled pri- or pre-let-7a-1 RNA within binding buffer
(50 mM Tris-Cl [pH 7.5], 100 mM NaCl, 10 mM b-mercaptoethanol, and 5%
glycerol) and incubated 40 min at room temperature (RT). Bound complexes
were resolved 5% native polyacrylamide gels at 200 V, 4C, for 2 hr. The
gels were dried, exposed, and detected by FLA-7000 (GE Healthcare). Band
intensities were quantified with ImageJ software and were used to calculate
the percentage of bound fractions.
Immunofluorescence
Immunofluorescence was performed as described (Piskounova et al., 2011),
with minor modification. Cells were fixed in 4% formaldehyde (HT5011;
Sigma-Aldrich) at RT for 20 min, washed three times with PBST (PBS contain-
ing 0.1% Tween 20, P7949; Sigma-Aldrich) for 15 min, permeabilized with
0.1% Triton X-100 (T8532; Sigma-Aldrich) in PBS, and blocked with blocking
solution (3% fetal bovine serum, A9647; Sigma-Aldrich) at RT for 1 hr. Cells
were reacted with primary antibodies against LIN28A, LIN28A-K135-me1,
SET7/9, and fibrillarin (diluted 1:200 with blocking solution) at 4C overnight
and washed six times with PBST. After washing, the cells were incubated
with Alexa-488- or Alexa-594-conjugated secondary antibodies (Invitrogen;
diluted 1:300) in the dark at RT for 1 hr and then washed six times with
PBST. During the washing step, DNA was counterstained with 40-6-diami-
dino-2-phenylindole (DAPI, D5942; Sigma-Aldrich). Finally, fluorescence
images were captured on a Zeiss LSM 510 confocal microscope equipped
with argon and helium-neon lasers (Carl Zeiss).
Alkaline phosphatase activity was measured using an alkaline phosphatase
detection kit (M8168; Sigma-Aldrich) according to the manufacturer’s guide-
lines, with minor modifications. Briefly, dissociated single H9 and NCCIT cells
were plated in four-well plates, incubated overnight, and transfected with
100 nM of LIN28A, SET7/9, or 60 nM of control siRNA. After 3 days of siRNA
transfection, the cells were fixed in citrate-acetone-formaldehyde solution
for 1 min at RT, incubated in AP staining solution (Naphthol/Fast Red violet)
for 15 min in the dark, and washed. Images were obtained under a microscope
(Olympus).
Quantitative RT-PCR
RNA samples were transcribed with the Improm Kit (A3802; Promega)
according to the manufacturer’s guidelines. Real-time PCR analysis was
performed with 2X h-Taq real-time mix (Solgent) and 20X Evagreen
(Biotium, 31000). PCRs were performed on CFX96 (Bio-Rad Laboratories)
with the primers (Tables S1 and S2) listed in Supplemental Experimental
Procedures.
Microarray
Total RNAs were hybridized to whole-human gene expression microarray
(Agilent) in accordance with the manufacturer’s instruction. Original data are
available in the National Center for Biotechnology Information’s Gene Expres-
sion Omnibus (accession number GSE53038).
ACCESSION NUMBERS
The Gene Expression Omnibus accession number for gene expression micro-
array analysis reported in this paper is GSE53038.nce of hESCs
A-, SET7/9-, and TUT4-depleted hESCs (A) and in LIN28A-depleted hESCs,
ermined by microarray analysis. The fold-change values (log2) and expression
T4, SOX2, and alkaline phosphatase staining in H9 cells subjected to siRNA-
th expression of control vector, LIN28A-siR or K135R-siR at the same time (D).
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